SMC3

Chr 10AD

structural maintenance of chromosomes 3

Also known as: BAM, BMH, CDLS3, CSPG6, HCAP, SMC3L1

This gene belongs to the SMC3 subfamily of SMC proteins. The encoded protein occurs in certain cell types as either an intracellular, nuclear protein or a secreted protein. The nuclear form, known as structural maintenance of chromosomes 3, is a component of the multimeric cohesin complex that holds together sister chromatids during mitosis, enabling proper chromosome segregation. Post-translational modification of the encoded protein by the addition of chondroitin sulfate chains gives rise to the secreted proteoglycan bamacan, an abundant basement membrane protein. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.041 OMIM phenotype
Clinical SummarySMC3
🧬
Gene-Disease Validity (ClinGen)
Cornelia de Lange syndrome · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
80 unique Pathogenic / Likely Pathogenic· 282 VUS of 787 total submissions
📖
GeneReview available — SMC3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.04LOEUF
pLI 1.000
Z-score 8.26
OE 0.00 (0.000.04)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
6.40Z-score
OE missense 0.28 (0.250.32)
178 obs / 630.1 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.04)
00.351.4
Missense OE?0.28 (0.250.32)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 0 / 79.5Missense obs/exp: 178 / 630.1Syn Z: -0.65
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSMC3-related Cornelia de Lange syndromeOTHERAD

This gene — mechanism propensity

DN
0.3196th %ile
GOF
0.3293th %ile
LOF
0.69top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 20% of P/LP variants are LoF · LOEUF 0.04

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

787 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic54
VUS282
Likely Benign273
Benign92
Conflicting39
26
Pathogenic
54
Likely Pathogenic
282
VUS
273
Likely Benign
92
Benign
39
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
10
16
0
0
26
Likely Pathogenic
6
47
1
0
54
VUS
13
218
43
8
282
Likely Benign
0
11
149
113
273
Benign
0
0
87
5
92
Conflicting
39
Total29292280126766

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

24 pathogenic / likely-pathogenic (of 32) ClinVar copy-number / structural variants overlap SMC3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SMC3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →